Cargando…
Sodium Valproate Use in Japanese Patients with Schizophrenia and Coronavirus Disease Is Associated with an Increased Risk of Pneumonia
Schizophrenia is a known risk factor for coronavirus disease (COVID-19) infection and severity, and certain psychotropic drugs have been linked to increased mortality in infected patients with schizophrenia. However, little evidence exists regarding this risk. We retrospectively examined the associa...
Autores principales: | Arai, Yusuke, Sasayama, Daimei, Kuraishi, Akira, Sahara, Reiko, Murata, Shiho, Tanaka, Akira, Amemiya, Kotaro, Usuda, Nobuteru, Kuraishi, Kazuaki, Washizuka, Shinsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532378/ https://www.ncbi.nlm.nih.gov/pubmed/37762894 http://dx.doi.org/10.3390/jcm12185953 |
Ejemplares similares
-
Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary study
por: Arai, Yusuke, et al.
Publicado: (2023) -
Association between Children’s Difficulties, Parent-Child Sleep, Parental Control, and Children’s Screen Time: A Cross-Sectional Study in Japan
por: Arai, Yusuke, et al.
Publicado: (2023) -
PT654. Suvorexant induced restless legs syndrome; a case report
por: Ogihara, Tomomi, et al.
Publicado: (2016) -
Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline
por: Nakamura, Toshinori, et al.
Publicado: (2017) -
PM344. Association between peripheral cytokine levels and cognitive abilities in children with autism spectrum disorder
por: Sasayama, Daimei, et al.
Publicado: (2016)